Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Does the new CF therapy Trikafta/Kaftrio change breath signals in children with cystic fibrosis?

Does the new CF therapy Trikafta/Kaftrio change breath signals in children with cystic fibrosis?

Resource Type

CF Research News

Authors

Elias Seidl, Andrew Zikic, Srdjan Micic, Rianne de Vries, Julie Avolio, Alexander Moeller, Felix Ratjen, Hartmut Grasemann

References

J Cyst Fibros 2026 Mar; 2026 Mar 24:S1569-1993(26)00081-0. doi: 10.1016/j.jcf.2026.03.

Document

File JCF-D-25-00576R1_FINAL_Seidl_12042026.docx [1]

Keywords

CFTR modulator treatment [2]
Cystic fibrosis [3]
Electronic nose [4]
Respiratory disease [5]
Respiratory infections [6]
Volatile organic compounds [7]

Date

Monday, March 23, 2026

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [8]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/does-new-cf-therapy-trikaftakaftrio-change-breath-signals-children

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-25-00576R1_FINAL_Seidl_12042026.docx [2] https://www.ecfs.eu/research-article-keywords/cftr-modulator-treatment [3] https://www.ecfs.eu/research-article-keywords/cystic-fibrosis [4] https://www.ecfs.eu/research-article-keywords/electronic-nose [5] https://www.ecfs.eu/research-article-keywords/respiratory-disease [6] https://www.ecfs.eu/research-article-keywords/respiratory-infections [7] https://www.ecfs.eu/research-article-keywords/volatile-organic-compounds [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines